Detalles de la búsqueda
1.
Self-reported distress and problems after treatment for gynecological cancer - Correlation between a short screening tool and longer measures of anxiety/depression and health-related quality of life.
Acta Obstet Gynecol Scand
; 103(2): 387-395, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37991142
2.
Self-reported cognitive impairment in cervical cancer survivors: A cross-sectional study.
Psychooncology
; 31(2): 298-305, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34516040
3.
Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer.
Acta Obstet Gynecol Scand
; 101(3): 313-322, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34964982
4.
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.
Lancet Oncol
; 22(4): 538-547, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33794207
5.
Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps.
Acta Oncol
; 54(9): 1607-13, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26213311
6.
MRI-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy.
Radiother Oncol
; 195: 110263, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38556173
7.
Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
Int J Radiat Oncol Biol Phys
; 116(4): 807-824, 2023 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36641039
8.
Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
J Clin Oncol
; 41(10): 1933-1942, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36599120
9.
Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors.
Radiother Oncol
; 181: 109501, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36720348
10.
Risk of recurrence after chemoradiotherapy identified by multimodal MRI and 18F-FDG-PET/CT in locally advanced cervical cancer.
Radiother Oncol
; 176: 17-24, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36113778
11.
Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study.
Radiother Oncol
; 168: 8-15, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35063582
12.
Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I Study.
Int J Radiat Oncol Biol Phys
; 112(2): 400-413, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34478833
13.
Risk Factors for Late Persistent Fatigue After Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: An Analysis From the EMBRACE-I Study.
Int J Radiat Oncol Biol Phys
; 112(5): 1177-1189, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34838868
14.
Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I Study.
Int J Radiat Oncol Biol Phys
; 113(2): 379-389, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35157992
15.
Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future.
Int J Radiat Oncol Biol Phys
; 112(3): 681-693, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34678431
16.
Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer.
Cancers (Basel)
; 13(6)2021 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33803531
17.
Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis.
Radiother Oncol
; 158: 312-320, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33545254
18.
Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study.
Int J Radiat Oncol Biol Phys
; 109(3): 688-700, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33068689
19.
Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis.
Radiother Oncol
; 158: 300-308, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33065183
20.
Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysis.
Radiother Oncol
; 163: 150-158, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34480958